We recommend authors to publish their Animated Abstract, along with the article abstract, to extend the coverage of the published articles.
Bentham Science has collaborated with Focus Medica, one of the world's largest publishers of expert animated atlases and videos in medicine and science, to create an Animated Abstract of the article. Animated Abstracts will be published as open access (free-to-view) and help summarize the essential discoveries/key findings of the research, highlight the importance of the article for further research and utilization in the relevant industry. Each professionally produced, full-colored animated abstract, in video format (length 3-5 minutes) is accompanied by an English or foreign language commentary.
Authors can avail this service against a fee to get the Animated Abstract published with the textual / graphical abstract on the Journal's homepage (for reference, please visit: http://www.eurekaselect.com/video.html).
It will serve to define and gain attention for the article. For more information, please view the ‘Author Guidelines’.
Vladimir P. Torchilin (68301 citations) Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine Northeastern University Boston, MA 02115 (USA) Biography
Biography of Vladimir P. Torchilin
Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.